PT - JOURNAL ARTICLE AU - Wei-jie Guan AU - Zheng-yi Ni AU - Yu Hu AU - Wen-hua Liang AU - Chun-quan Ou AU - Jian-xing He AU - Lei Liu AU - Hong Shan AU - Chun-liang Lei AU - David S.C. Hui AU - Bin Du AU - Lan-juan Li AU - Guang Zeng AU - Kwok-Yung Yuen AU - Ru-chong Chen AU - Chun-li Tang AU - Tao Wang AU - Ping-yan Chen AU - Jie Xiang AU - Shi-yue Li AU - Jin-lin Wang AU - Zi-jing Liang AU - Yi-xiang Peng AU - Li Wei AU - Yong Liu AU - Ya-hua Hu AU - Peng Peng AU - Jian-ming Wang AU - Ji-yang Liu AU - Zhong Chen AU - Gang Li AU - Zhi-jian Zheng AU - Shao-qin Qiu AU - Jie Luo AU - Chang-jiang Ye AU - Shao-yong Zhu AU - Nan-shan Zhong AU - on behalf of China Medical Treatment Expert Group for 2019-nCoV TI - Clinical characteristics of 2019 novel coronavirus infection in China AID - 10.1101/2020.02.06.20020974 DP - 2020 Jan 01 TA - medRxiv PG - 2020.02.06.20020974 4099 - http://medrxiv.org/content/early/2020/02/09/2020.02.06.20020974.short 4100 - http://medrxiv.org/content/early/2020/02/09/2020.02.06.20020974.full AB - Background Since December 2019, acute respiratory disease (ARD) due to 2019 novel coronavirus (2019-nCoV) emerged in Wuhan city and rapidly spread throughout China. We sought to delineate the clinical characteristics of these cases.Methods We extracted the data on 1,099 patients with laboratory-confirmed 2019-nCoV ARD from 552 hospitals in 31 provinces/provincial municipalities through January 29th, 2020.Results The median age was 47.0 years, and 41.90% were females. Only 1.18% of patients had a direct contact with wildlife, whereas 31.30% had been to Wuhan and 71.80% had contacted with people from Wuhan. Fever (87.9%) and cough (67.7%) were the most common symptoms. Diarrhea is uncommon. The median incubation period was 3.0 days (range, 0 to 24.0 days). On admission, ground-glass opacity was the typical radiological finding on chest computed tomography (50.00%). Significantly more severe cases were diagnosed by symptoms plus reverse-transcriptase polymerase-chain-reaction without abnormal radiological findings than non-severe cases (23.87% vs. 5.20%, P<0.001). Lymphopenia was observed in 82.1% of patients. 55 patients (5.00%) were admitted to intensive care unit and 15 (1.36%) succumbed. Severe pneumonia was independently associated with either the admission to intensive care unit, mechanical ventilation, or death in multivariate competing-risk model (sub-distribution hazards ratio, 9.80; 95% confidence interval, 4.06 to 23.67).Conclusions The 2019-nCoV epidemic spreads rapidly by human-to-human transmission. Normal radiologic findings are present among some patients with 2019-nCoV infection. The disease severity (including oxygen saturation, respiratory rate, blood leukocyte/lymphocyte count and chest X-ray/CT manifestations) predict poor clinical outcomes.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementSupported by Ministry of Science and Technology, National Health Commission, National Natural Science Foundation, Department of Science and Technology of Guangdong Province.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon request to the corresponding author.